UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000003387 |
|---|---|
| Receipt number | R000004112 |
| Scientific Title | Phase II Study of Carboplatin+Pemetrexed+Bevacizumab in chemo-naive patients with stage IIIB and IV non-squamous non-small cell lung cancer(NSCLC). |
| Date of disclosure of the study information | 2010/04/01 |
| Last modified on | 2017/08/21 08:24:03 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/03/27 15:20:41 | ||
| 2 | Update | 2010/04/01 20:26:23 | Recruitment status |
|
| 3 | Update | 2013/04/27 09:07:37 | Name of person sending information Organization Division name Address Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 4 | Update | 2014/02/19 20:46:12 | Email Last name of contact person Last name of contact person Address Address TEL Category of Funding Organization |
|
| 5 | Update | 2014/02/19 20:47:11 | Recruitment status Publication of results |
|
| 6 | Update | 2017/08/21 08:24:03 | Name of primary person or sponsor Organization |
